Long-Term Safety and Efficacy of Allogenic Umbilical Cord–Derived MSCs for Rotator Cuff Disease
Official title: A Single Center, Open Label, Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease
Run by Seoul National University Hospital · NCT07374679 · Data updated 2026-11-12
This long-term follow-up checks whether allogenic umbilical cord–derived mesenchymal stem cells are safe and helpful for people with rotator cuff disease who previously received the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 21 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul, Korea) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | May 30, 2031 |
| Study ends | January 30, 2032 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07374679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People who previously received the investigational MSC product in the Phase 1/2a trial (ASB-IP-001) and consented to long-term follow-up.
✕Probably not a fit
Patients with inability to be contacted or who face practical barriers to follow-up, or those deemed unsuitable by investigators due to safety risks or adherence concerns.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational follow-up study tracks patients who previously received an investigational allogenic umbilical cord–derived mesenchymal stem cell therapy for rotator cuff disease. It aims to gather long-term safety and efficacy data over time. Eligible participants include those from a prior Phase 1/2a trial who consented to continued monitoring. The study relies on routine follow-up assessments to monitor health status and any lasting effects. Enrollment is limited to sites at major Seoul medical centers in Korea.
Why it matters
Potential benefit: If successful, the study could clarify long-term safety and whether the therapy provides ongoing relief or functional benefits for rotator cuff disease.
How similar studies have gone: Prior similar studies have provided safety and durability data for stem cell therapies in musculoskeletal conditions, but long-term results for this specific product are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects who received the investigational medicinal product in the Phase 1/2a clinical trial (ASB-IP-001). * Subjects who voluntarily agreed to participate in this long-term follow-up study and provided written informed consent. Exclusion Criteria: * Subjects who cannot be contacted by any means, including telephone, mail, or e-mail, and for whom follow-up assessment is therefore not feasible. * Subjects deemed inappropriate for participation in this long-term follow-up study at the investigator's discretion, including: * Cases in which participation in the study may pose a significant risk to the subject's health or safety; ② Cases in which long-term follow-up visits or assessments are practically impossible due to cognitive impairment, communication difficulties, or similar conditions; ③ Cases in which continued participation in follow-up is unlikely due to difficulty adhering to the study schedule (e.g., prolonged hospitalization, long-term residence abroad).
Where it's running
-
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Seoul, Korea, South Korea Recruiting
Study contacts
- Study coordinator: KeeJeong Bae, Principal Investigator
- Email: grant903@gmail.com
- Phone: +82-10-5202-7469
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Functional electrical stimulation plus shoulder exercises for older adults with rotator cuff pain
In older adults with rotator cuff–related shoulder pain, this study tests whether adding functional electrical stimulation to a shoulder exercise program improves muscle coordination and reduces impingement compared with exercises alone.
-
Using stem cells to repair large rotator cuff tears
This study is testing whether injections of stem cells from umbilical cords can help people with large rotator cuff tears recover better after surgery.
-
Using stem cells from umbilical cords to treat rotator cuff disease
This study is testing if injections of stem cells from umbilical cords can help people with rotator cuff disease who haven't found relief from other treatments.
-
Understanding the significance of rotator cuff disease
This study is trying to learn more about how rotator cuff disease affects patients by using shoulder questionnaires and exercise to see what improvements matter most to them.
-
Botulinum toxin for treating shoulder pain from degenerative rotator cuff disease
This study is testing if botulinum toxin can help relieve shoulder pain in people over 40 with degenerative rotator cuff disease.
-
Rotator cuff repair with biceps rerouting and dermal graft augmentation for large, difficult tears
This study tests a combined surgical approach to see if it helps tendon retear rates in adults with large rotator cuff tears that are hard to repair.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.